Abstract
Psoriasis is grouped under chronic, non-communicable skin conditions. This inflammatory condition is way beyond physical manifestations, but more psychological and emotional to patients whose social and interpersonal relationships are affected. Termed to simple words psoriasis affects the patients ‘Quality of Life’. The primary concern of health care is to prioritize the stigma caused by this skin condition. Incidence has no origin instead this condition has several factors associated with it and the cause of the disease in each patient differs. Genetic and immunological conclusions of psoriasis have a strong base to consider the incidence of the disease. This review discusses the history, epidemiology, Prevalence, triggers of the disease, FDA-approved drugs, and several herbal drugs that have shown pharmacological activity against psoriasis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
